CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 31 filers reported holding CORREVIO PHARMA CORP in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $120,000 | -7.7% | 60,280 | 0.0% | 0.00% | – |
Q2 2019 | $130,000 | -27.8% | 60,280 | +6.0% | 0.00% | – |
Q1 2019 | $180,000 | +28.6% | 56,880 | +1.7% | 0.00% | – |
Q4 2018 | $140,000 | -36.4% | 55,940 | +2.3% | 0.00% | – |
Q3 2018 | $220,000 | +4.8% | 54,660 | -2.0% | 0.00% | – |
Q2 2018 | $210,000 | – | 55,760 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 250,000 | $103,000 | 0.68% |
Tamarack Advisers, LP | 2,500,000 | $1,019,000 | 0.23% |
Virtu Financial LLC | 287,972 | $118,000 | 0.01% |
ARS Investment Partners, LLC | 147,818 | $61,000 | 0.01% |
Pacifica Partners Inc. | 2,665 | $1,000 | 0.00% |
OXFORD ASSET MANAGEMENT LLP | 116,653 | $48,000 | 0.00% |
K.J. Harrison & Partners Inc | 12,860 | $5,000 | 0.00% |
TORONTO DOMINION BANK | 153 | $0 | 0.00% |
SCOTIA CAPITAL INC. | 19,000 | $8,000 | 0.00% |
MORGAN STANLEY | 99,852 | $41,000 | 0.00% |